Lebensqualität in Bezug auf Sexualität nach vaginaler Applikation von ultra-niedrig dosiertem Estriol (Gynoflor®) bei Brustkrebspatientinnen mit atropher Vaginitis unter Aromatasehemmer Therapie
M Mögele(University Hospital Regensburg), Sandra Buchholz, P. Neven(Universitair Ziekenhuis Leuven), Olaf Ortmann(University of Regensburg), Anneleen Lintermans(Universitair Ziekenhuis Leuven), Gert Bellen(Flemish Community), Gilbert Donders(Institut Scientifique de Santé Publique), P. J. Grob, V. Prasauskas
Cited by 0
Related Papers
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy
|BJOG An International Journal of Obstetrics & Gynaecology|2009|436
Aerobic vaginitis: no longer a stranger
|Research in Microbiology|2017|242
Aerobic vaginitis in pregnancy
|BJOG An International Journal of Obstetrics & Gynaecology|2011|186
Prediction of recurrence after treatment for high‐grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation
|BJOG An International Journal of Obstetrics & Gynaecology|2006|139